Skip to main content
SpringerLink
Log in

The antiretrovirals tenofovir, indinavir, atazanavir and lopinavir increase the risk of chronic kidney disease (CKD)

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kirk O, Mocroft A, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips A, Ledergerber B, Lundgren J, for the EuroSIDA Study Group.Chronic Kidney Disease and Exposure to ART in a Large Cohort with Long-term Follow-up: The EuroSIDA Study. 17th Conference on Retroviruses and Opportunistic Infections: abstr. 107LB, 16 Feb 2010. Available from: URL: http://retroconference.org/2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The antiretrovirals tenofovir, indinavir, atazanavir and lopinavir increase the risk of chronic kidney disease (CKD). React. Wkly. 1294, 3 (2010). https://doi.org/10.2165/00128415-201012940-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012940-00007

Keywords

Search

Navigation